PHAROS funding rates and arbitrage
Updated 2026-10-29 15:26 UTC
Best PHAROS arbitrage after every cost
No PHAROS pair nets a profit at this size right now.
At $10,000 per side, held 7 days, after taker fees, order-book slippage and carry.
PHAROS funding rate on every exchange
| Exchange | Contract | Rate | Every | Annualised | Settled 7d, annualised | Open interest | Next settlement |
|---|---|---|---|---|---|---|---|
| BloFin | PHAROS-USDT | 0.0064% | 4 h | +14.0% | +15.4% | $325.1K | 2026-10-29 16:00 |
| Bitunix | PHAROSUSDT | 0.0059% | 4 h | +13.0% | +15.6% | — | 2026-10-29 16:00 |
| MEXC | PHAROS_USDT | 0.0050% | 4 h | +10.9% | +16.4% | $295K | 2026-10-29 16:00 |
| WhiteBIT | PHAROS_PERP | 0.0050% | 4 h | +10.9% | +11.0% | $1.3M | 2026-10-29 16:00 |
| BingX | PHAROS-USDT | 0.0050% | 4 h | +10.9% | +16.1% | $1.3M | 2026-10-29 16:00 |
| Bybit | PHAROSUSDT | 0.0050% | 4 h | +10.9% | +11.0% | $1M | 2026-10-29 16:00 |
| Binance | PHAROSUSDT | 0.0050% | 4 h | +10.9% | +16.4% | $5.7M | 2026-10-29 16:00 |
Cost to enter $10,000 of PHAROS
| Exchange | Contract | Fee + slippage | Source |
|---|---|---|---|
| MEXC | PHAROS_USDT | 3.6 bp | top of book only |
| BingX | PHAROS-USDT | 5.8 bp | top of book only |
| Binance | PHAROSUSDT | 6.6 bp | top of book only |
| BloFin | PHAROS-USDT | 12.4 bp | top of book only |
| Bybit | PHAROSUSDT | 17.5 bp | top of book only |
Taker fee plus slippage of a market buy of $10,000 from the mid price, at standard (VIP0) fees.
Questions
Is PHAROS funding-rate arbitrage profitable right now?
Not at $10,000 per side for 7 days: no PHAROS pair shows a verified profit after fees and order-book slippage right now. Rates change every hour; the live page re-ranks continuously.
Which exchange has the highest PHAROS funding rate?
BloFin at +14.0% a year (0.0064% every 4 h); the lowest is Binance at +10.9%. A positive rate is paid by longs to shorts, a negative one by shorts to longs.
The method behind every number on AfterFees is published; Pro opens each figure into its line-by-line calculation. Estimates from current data, not investment advice. We never hold funds or trade for you.